YH16410
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YH16410, covering 2014-07-08 to 2014-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia [Phase 3]